Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prothena Corp Public (PRTA) Return on Sales (2016 - 2025)

Prothena Corp Public has reported Return on Sales over the past 14 years, most recently at 1025.81% for Q4 2025.

  • Quarterly results put Return on Sales at 1025.81% for Q4 2025, down 99850.0% from a year ago — trailing twelve months through Dec 2025 was 25.2% (down 2429.0% YoY), and the annual figure for FY2025 was 25.21%, down 2430.0%.
  • Return on Sales for Q4 2025 was 1025.81% at Prothena Corp Public, down from 15.12% in the prior quarter.
  • Over the last five years, Return on Sales for PRTA hit a ceiling of 0.78% in Q3 2021 and a floor of 1444.78% in Q1 2024.
  • Median Return on Sales over the past 5 years was 27.79% (2021), compared with a mean of 161.05%.
  • Biggest five-year swings in Return on Sales: plummeted -142317bps in 2024 and later skyrocketed 142350bps in 2025.
  • Prothena Corp Public's Return on Sales stood at 28.28% in 2021, then surged by 100bps to 0.13% in 2022, then crashed by -167978bps to 213.5% in 2023, then surged by 87bps to 27.31% in 2024, then tumbled by -3656bps to 1025.81% in 2025.
  • The last three reported values for Return on Sales were 1025.81% (Q4 2025), 15.12% (Q3 2025), and 28.45% (Q2 2025) per Business Quant data.